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Introduction 
Introduction 
The most important forefront research area of bioinorganic chemistry is the medicinal 
inorganic cliemistry [1-3]. It deals with the design of novel metal-based chemotherapeutic 
and diagnostic agents, metal ion sequestering agents and detoxification [4]. This field has 
gained much impetus, after the disco\'er> of c/.s-diaminedichloroplatinum(II) (cisplatin) 
by Rosenberg - an archetypical antitumour drug v\idely used for treating solid 
malignancies [5,6]. Although the drug is one of the most active anticancer drugs and is 
curative in some tumour types [7|, its use is limited by both its side effects and acquired 
cellular resistance. So more efficacious, less toxic and target specific noncovalently DNA 
binding metal-based anticancer drugs are being de\'eloped [8]. To overcome the problems 
of resistance and toxicity, the first object is to select the design of organic scaffold which 
bears donor sites for the coordination of metal ions. There are number of polynuclear 
ligands. to name a few, Schiff bases [9.10], Ihiazolidinones [11], thiasemicarbazones [12, 
13], imidazoles [14.15]. amino acids [16.17] which ha\e been extensively explored. The 
carboxylate group is one of the niost \sideh used bridging ligands for designing 
polynuclear complexes with interesting structures and biological properties [18,19]. Its 
versatility as a ligand is illustrated b) the variet) of its coordination modes (Scheme 1) 
when acting as a bridge [20-22]. the most common being syn-syn, syn-anli and cmti-cmti 
modes. 
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Scheme 1 
Pyridine-2-carboxylic acid, gencralh called as picolinic acid, is an efficient bidentate 
N - 0 donor. Picolinic acid is a ver> importanl ligand incorporated into some enzymes 
and an active agent in many drugs [23], The structures, chemical properties and 
biological activities of picolinic acid and some metal picolinates have been studied [24-
26]. 
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The three isomers of pyridine-carboxylic acid are 2-picolinic acid, 3-picolinic acid and 4-
picolinic acid (Scheme 2). which contain both 0- and N~donors, exhibit versatile 
coordination modes to metal ions. .Among them. 2-picolinic acid is most commonly used 
to obtain metal complexes. 
Picolinic acid is biosyntliesized in the Iner and kidneys from the amino acid tryptophan, 
and stored in the pancreas during digestion, secreted into the intestine. It is present in 
dietary additives as a carrier of the di\alent zinc or chromium cations and has been found 
to be chelator of vital trace elements zinc, manganese, copper, iron and molybdenum in 
the human bod> [27]. This stems interest in picolinic acid ternar} complexes for robust, 
less toxic metal-based chcmotherapcutics. Structure-activity relationships [28-30], 
demonstrate that the oxidatiNC state of metal, the coordination number and the kind of 
coordinated ligands show different biological and spectroscopic properties. In particular, 
there is a direct relationship between a chemical structure and antimicrobial or antitumour 
activity of chemical compounds. Among the metal complexes 3d metal ion series, Cu(Il), 
Ni(II), Zn(II) complexes, besides Co(ll) have been widely studied owing to their 
biocompatibility in human bod) [31 J. Most of metalloproteins either contain one of them 
or a combination of two in close proximit\ or are responsible for important 
biotransformation directh' or indirectly Copper complexes are known to have broad 
spectrum of biological actions \iz; antiinflammatory, antiarthritic, antiulcer, 
anticonvulsant and antitumour agents 132-34] .It has been shown that copper accumulates 
in tumours due to the selecti\e permeabilil} of cancer cell membranes to copper 
compounds [35]. Because of this, a number of copper complexes have been screened for 
anticancer activity and some of them were foimd active both in vivo and in vitro [36], 
Sadler and coworkers have observed [37] that mixed ligand bis(salicylato)copper(II) 
complexes exhibit cytotoxic and antiviral activities. Very recently Ng and coworker [38] 
have prepared ternary copper(II) complexes of ethylenediaminediacetic acid(H2edda) and 
l.lO-phenanthroline(phen). which strongly bind to DNA and also regulate apoptosis . 
Organotin(IV) complexes exhibit remarkable activity as emphasized in recent surveys 
[39-41]. To date, several research articles ha\e dealt with structures of organotin(IV) 
carboxylates containing a N-donor atom in an aromatic ring. Pyridine-2,6-dicarboxylic 
acid (or dipicolinic acid) form stable chelates with simple metal ions and oxo-metal 
cations and can display \'arying coordination behaviour functioning as a multidentate 
ligand [42]. A very important characteristic of these ligands is their diverse biological 
activity. Pyridine-2,3-dicarbox}lie acid is an intermediate in the tryptophan degradation 
pathway and is a precursor for NAD [41 J. i,. Nagy et al. have synthesized a series of 
organotin(IV) complexes v\ith pyridine mono- and dicarboxylic acid and characterized by 
FT-IR and "^Sn NMR and Mossbauer spectroscopic measurements [42]. In another 
report [43] bis(dicyclohexylammonium) bis(2,6-pyridinedicarboxylato)dibutylstannate, 
"Bu2Sn(IV)'^ complexes were synthesized and it was found that tin has seven-fold 
coordination environment on the basis ol'' ''""Sn CP/MAS NMR chemical shift (5 = -424.9 
ppm). hi this complex, one 2.6-pyridinedicarbox}lato ligand chelates to the tin atom, 
while another binds through onl} one carbox}late end. The anh}drous compound showed 
higher in vitro antitumour acli\ii} than those of cisplatin or carboplatin. 
R2Sn(IV)2.6-pyridinedicarboxylates exhibited antitumour activity in vitro [44]. Atassi 
observed that water soluble organolin(IV) compounds are likely to be more active than 
complexes that are soluble in organic solvoUs |45]. 
Gielen et al. [44,46] have prepared some telraethylammonium (diorgano)-halogeno(2,6-
pyridine-carboxylato)stannatcs, (halogen= CT. F') and found that the in vitro antitumour 
activity was higher than the other earbo\\iate eompounds owning to higher water 
solubihty under physiological conditions. 
Triorganotin(IV) carboxylates generally adopt three idealized structures [47]. 
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Scheme 3. Structures of the triorganutin(IV) carboxylates. 
A Th (A), in which the -COO' group is monodentately coordinated. In (B). distorted Tbp 
with facial organic groups and chelating carboxylate group, or a tram Tbp structure in 
which planar R3Sn(IV) units are linked by bidentate (CI) or anisobidentate (C2) 
carboxylate bridges. Additionally, there are more possibilities in the case of pyridine 
mono- and dicarboxylic acids, differing in the ring position of the carboxylic group (ID 
and E) (Scheme 3). Basu Baiil and his co-worker ha\e reported several monomenc mixed 
tri- and diorganotin complexes deri\ed irom Schiffbase ligands. where the tin atom in 
diorganotin moieties has been invohed in intramolecular N ^ S n interactions [48]. More 
recently, polymeric organotin carbo\\lates ha\c attracted more attention due to their 
interesting and various supramolecular architectures and topologies [49,50]. In articles 
several novel and interesting organotin pohmers with carboxylate ligands ha\e reported 
[50]. 
Deacon et al. [51] ha\e studied the IR spectra oi" acetate and trifluoroacetato metal 
complexes. The follow-ing conclusions were drawn: (i) When the -COO' group 
coordinates to the metal ion in a monodentate manner, the difference between the 
wavenumbers of the as}'mmetric and symmetric carboxylate stretching bands. 
Av = (Vas COO" - Vs^ mCOO'), is larger than that observed for ionic compounds, (ii). When 
the ligand chelates, Av was considerabI\ smaller than that observed for ionic compounds, 
but for asymmetric bidentate coordination the \alue were in the range characteristic of 
monodentate coordination, (iii) The characteristic A\' for structures were larger than that 
for chelates ions and nearly the same as that observed for ionic compounds. On the above 
basis, it was possible to distinguish between the -COO"group coordination modes. 
W. Lewandoski et al. [52] ha\e shown the LV spectra of picolinic acid and Ag(l), Zn(II), 
Ni(II). Cu(II) picolinate complexes. \n mciease in the delocalization energy of K 
electrons and stabilization of the aromatic system of ligands results in bathochromic shift 
of TT ^ 7t* bands observed in UV spectra. The shift is caused by the decrease in the 
energy gap between bonding and antibonding orbital and illustrates well the tendencies in 
certain group of metals to perturb aromatic s\'stem of ligands to greater or lesser extent. 
For Zn(II), Ni(II). Cu(II) picolinates the maxima of n -^ n* bands were found to be 
shifted bathochromically and located within the range of 214-215; 264-265 nm; while 
picolinic acid absorbed at 212 and 264 nm. The chemical shifts of protons and carbon 
atoms from the NMR spectra of picolinic acid and Ag(l). Zn(Il) picolinates are shown in 
Table 1. hi 'H NMR spectra of studied picolinates three protons (3,4 and 5) are shifted 
paramagnetically as compare to 'll NMR spectrum of picolinic acid and one proton (6) is 
shifted diamagnetically [52]. 
, ( ) H 
Table 1. The chemical shifts of protons and carbons in the H and '^C NMR spectra 
of picolinic acid and Zn(II) picolinate. 
Chemical shift of carbon atoms (ppm) 
1 2 3 4 5 
Picolinic acid 
166.25 149.46 140.41 137.51 127.15 
Zn(ll) picolinate 
65.45 150.58 146.31 140.44 126.74 
6 
124.74 
123.77 
Chemical shift of protons (ppm) 
3 4 5 6 
7.62 7.96 8.05 8.70 
7.68 8.16 8.20 8.38 
The bimetallic Cu(II) complexes ha\ e further attracted much attention as to correlate the 
spin-spin interaction between the two metal centres and the stereochemistry of the 
complexes [53,54]. The binuclear Cu(ll) complexes which mimic the "type 3' active site 
of copper proteins were examined \er_\ cxtensiveh with studies of magnetic interactions, 
ligand environment and oxygen uptake of these active sites [55.56]. Many heterometallic 
complexes comprising the fN4(H20)nr' (n = 5,6) moiet> are known [57,58], M. V. 
Kiriliova et al. [59] prepared complexes of dipicolinic acid having formulation 
[M(H20)5M-(dipic)2].mH20 (M/M' = Cu'VCo" (1). Cu"/Ni" (2). Cu'VZn" (3), Zn'VCo" 
(4), Ni'VCo" (5), 1-5 m = 2-3; H:dipic = dipicolinic acid), appear to constitute the first 
reported penta or hexaaqua copper, nickel or zinc species. All complexes 1-5 have been 
characterized by IR, UV-\is and atomic absorption spectroscopies, elemental analysis 
and X-ray diffraction single crystal analyses (for 1 and 2). The first basket weave 
framework topology of Sm-Ni heterometallic complex with picolinic acid as bridging 
ligand showing two different coordination modes of piconilic acid were characterized 
[60]. They were explored espcciall\ for metal-complex based magnefic materials [61]. 
However, there are scarce reports on DNA binding studies of such complexes. 
The imidazole moiety, is a basic binding site for the majority of metal ions including 
Cu(II) [62]. The metal ion coordination generalh takes place via N(l) or N(3) atoms of 
imidazole as is found in a great \ariety of iron, zinc or copper proteins including 
myoglobin and other heme proteins, carbonic anhydrase. carbox}'peptidase and blue 
copper proteins. Another group of metalloenzymes contains the imidazole moiety as a 
bridging ligand (e.g. superoxide dismutase and tyrosinase) where botli nitrogen atoms of 
the negatively charged imidazolato residue take part in metal binding [63]. 
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Figure 1. Catalysis cycle for Cu.Zn-siipcroxide dismutase containing imidazole of a 
histidine side chain as an ancillary ligands. 
The interaction of a novel binuclear copper(Il) complex [Cu2(Dmbiim)4(H20)2](C104)4 
6H2O, where Dmbiim = 1 l.r-DiiTiethyl-2.2'-Dimethyl-2.2"-biimidazole with DNA has 
been investigated using electronic absorption spectroscopy, fluorescence spectroscopy, 
viscosity measurement and CNCHC \oltammetr\. These results revealed that the Cu(H) 
9 
complex interacted with DNA through minor groove binding [64]. hi addition, 
imidazoles are a common component of a large number of natural products and 
pharmacologically active molecules |65J. Fherelbre. imidazole and its derivatives are 
important target analytes. It v\as reported that the metal coordination compound of 
imidazole could inhibit tumor growth b\ interacting with DNA [66-68]. fhe presence of 
an imidazole moiety in biological molecules has encouraged the studies of Hi biim-
containing transition metal complexes {69,70]. Fumour cells are distinguished from 
normal body cells by the loss of genetic control of their life span. Likewise, the 
existences of neighbouring cells are impaired which leads to the uncontrolled growth of 
tumour tissue. In normal cells, these processes are restrained and regulated by 
protooncogenes, and cancer ma} thus result from changes of these genes or their 
expression. According to this basic concept of carcinogenesis, cisplatin is believed to 
exert its c}1ostatic effect primarih through coordination w'ith DNA in the cell nucleus 
while reactions in other regions, e.g. with serum proteins, cause undesired side effects. 
From experiments with second-generation compounds it is know-n that the mode of action 
may actually be quite complex; depending on the t\'pe of platinum compound there is 
more or less inhibition of DNA, RNA or protein synthesis [71], Few studies about the 
interaction between the transition metal complexes of l,r-dimethyl-2.2"-biimidazole 
(Dmbiim) and DNA have been reported, and most of the studies are limited in the 
structure characterization [72]. To disco\er no\-el DNA binding and cleavage reagent 
containing Dmbiim ligand. binuclear Cu(II) complex 
10 
[Cu2(Dmbiim)4(H20)2](C104)4.6H:0. where Dmbiim = l.r-Dimethyl-2.2"-biimidazole 
was synthesized and interacted with DNA. Complex-DNA interactions were investigated 
using electronic absorption spectroscop\. iluopresence spectroscopy and voltamnietry 
These results revealed that the Cu(II) complex interacts with DNA through minor groove 
binding J73J. Electronic spectral studies of fCu2(Dmbiim)4(H20)2]'^ ^ revealed that the 
maximal absorption of EB at 470 nm decreased and shifted to 479 nm in the presence of 
DNA. 'h}pochromic efffect" which was characteristic of intercalation (Figure 2). 
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Figure 2. The visible absorpnon spettra of 4 2 xlO-5 M EB(a). (a)+6 '"3x10-5 M DNA 
(b): (b) + 6.76x10-5 M [Cu2(Dmbum)4(H20)2|^ "fcy 
Emission spectra of EB bound to DNA in the absence and presence of complex 
[Cu2(Dmbiim)4(H20)2] ^ are shi)\\n in figure 3. The addition of the complex to DNA 
pretreated with EB causes an appreciable reduction in fluorescence intensity, indicating 
that [Cu2(Dmbiim)4(H20)2]'^ ' complex competes with EB to bind with DNA. The K value 
in the scatchard plot changed but the n value did not change, which indicates that the 
complex binds to DNA by competitive inhibition. The competitive inhibition is probablx 
due to the complex interaction with DNA through minor groove binding, blocking 
potential intercalation sites of EB. 
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Figure 3. Fluoresence spectra of the binding, of EB to DNA in the absence and presence 
of increasing amounts of fCu:(Dnibiii}ijj(H:()):J \ The inset is stern-volmer quenching 
plot. R = [Cu2{Dmbiim)4(H20):j'' [DNA]. 
n-l+. The cyclic voltammograms of jCu2(Dmbiim).)(H20)2] at a bare EPG (solid line) and 
DNA/EPG (dashed line) (Figure 4). Compared to the peak currents for 
[Cu2(Dmbiim)4(H20)2]"*^ in solution at the same concentration at the bare EPG electrode. 
the peak currents were lowei at the DNA/EPG electrode coupled with a obvious shift in 
the pealc (Cu(0)/Cu(I)) potential to positive Ei 2 \alue shifted to more positive value 
suggesting that the [Cu2(Dmbiim)4(H20)2]'^ ^could bind to DNA by electrostatic binding 
[73] 
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Present Work 
Transition metal complexes deri\cd from ar} 1 /alkxi - carboxylic acid have been much 
explored as an enz)'matic model and pharmaceutical agents. Picolinic acid being body's 
prime natural chelator of trace elements is an important organic scaffold. Since it is 
present in dietary additives as a carrier of divalent chromium or zinc cations, it displays 
more biocompatibility to the biological systems and together with imidazole (most 
prominent and prevalent ligand in metalloproteins) metal complexes dispenses its role for 
complementary interaction with the drug target DNA at the molecular level. Sn(lV) ions 
modulate and further tune the complex for site specific binding interaction 
We have designed a new metal- based potential anti cancer agent derived from pyridine 
2 carboxylic acid and imidazole copper(lI)/'Nickel(Il) and tin(IV) metal ions. In this 
work, new complexes of the type 1-3 (C|2Hi2N206SnCl 2 [1], C|8H26N60ioNiSnCl 2 [2], 
Ci8H26N60|oCuSnCl 2 [3]) ha\ing Sn(IV) monocationic species 1. Ni (II) - Sn(IV) 2 and 
Cu(II) - Sn(IV) 3 bimetallic cores v\ere synthesized and characterized by various 
spectroscopic (IR. H, '"'C. and " Sn NMR, EPR, UV-visible) and analytical techniques. 
The interactions of new heterobimetallic complexes towards DNA were done to ascertain 
the mode of binding and mechanistic pathway. To evaluate the binding affinity, various 
biophysical methods were employed \'iz, absorption, fluorescence and cyclic 
voltammetry studies. 
14 
Experimental 
EXPERIMENTAL METHODS 
The following techniques were emplo}ed: 
1. Characterization techniques 
1.1 Infrared spectroscopy 
1.2 Ultra-violet and visible speclroscop)' 
1.3 Nuclear magnetic resonance spectroscopy 
1.4 Electron paramagnetic resonance spcctroscop) 
1.5 Molar conductance measurements 
2. DNA binding studies 
2.1 Cyclic voltammetry 
2.2 Absorption spectral studies 
2.3 Fluorescence spectral studies 
1. Characterization techniques 
1.1 Infrared spectroscopy 
The infrared spectroscopy is a useful technique to cliaracterize a compound. It results 
from transition between \ibrational and rotational energy levels. IR region of the 
electromagnetic spectrum co\ers a \\ide range of \\a\elength from 4000 to 400 cm"' it 
has been found that in IR absorption, some of the \'ibrational frequencies are associated 
with specific groups of atoms and remain same irrespective of the molecules in which the 
group is present. These are called characteristic frequencies [74] and their constancy 
results from the constancy of bond force constants from molecule to molecule. The 
important observation that the IR spectrum of a complex molecule consists of 
characteristic group frequencies makes IR spectroscop}', unique and powerful tool in 
structural analysis. 
1.2 Ultraviolet and visible spectroscopy 
When a molecule absorbs radiation, its energy is increased. This increased energy is 
equal to the energy of the incident photon expressed b\ the relation 
E - hv 
E = he ' /. 
where h is Planck's constanl, v is llie frequency. A is the wavelength of the radiation and 
c is the velocity of light. N4ost of the compounds absorb light in the spectral region 
between 200 and 800 nm resulting in the excitation of electrons of the molecules from 
ground state to higher electronic states. In transition metals, all the five d-orbitals viz. dxy, 
dyz, dxz, d/ and dx -y" are degenerate. However, in coordination compounds due to the 
presence of ligands, this degeneracy is destroyed and d orbitals split into two groups t2g 
(dx), dvz and dxz) and Co {d/ and d-f.y') in an octahedral complex and t2 and e in a 
tetrahedral complex. The set of t^ u orbitals goes below the original level of degenerate 
orbitals in octahedral complexes and the case is reversed in tetrahedral complexes (Figure 
5a.5b). 
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Figure 5a. Splitting of the d energy levels in an oeiahedral complex. 
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Figure 5b. Ligand field spUtling of a tetrahedral complex, 'g' subscript is omitted in Td 
symmetry. 
At energy higher than the Hgand field absorption bands, we commonly observe one or 
more very intense bands that go off scale unless log £ is plotted. These are the charge 
transfer bands, corresponding to electron transfer processes that might be either ligand-to-
metal (L —^  M) or metal-to-ligand (M -^ I.)- In case of octahedral complexes M --^  L 
transitions occur for metal ion complexes that have filled, or nearly filled. t2g orbitals with 
ligands that have low lying empty orbitals. The L -^ N4 charge-transfer (C-T) spectra 
have been studied more thoroughly. The electron density is transferred from the ligand to 
the metal. This is favoured when the central metal has a high oxidation stale, and is 'short 
of electrons'. The ligand n orbitals are lower in energy than the metal t2g orbitals. No net 
oxidation - reduction usualh occurs, because of the short lifetime of the excited state 
[75]. 
1.3 Nuclear magnetic resonance spectroscopy 
The nuclei of certain isotopes possess a meclianical spin or angular momentum. The 
NMR spectroscopy is concerned with nuclei having nuclear spin quantum number 
I = 1/2, example of which include'Fl,'-'C,' 'P,"'Sn and'V. 
For a nucleus with I = 1/2. there are two \alues for the nuclear spin angular momentum 
quantum number mi = ±1/2 which are degenerate in the absence of a magnetic field. 
However, in the presence of the magnetic field, this degeneracy is destroyed such that the 
positive value of ni| corresponds to the lower energy state and negative value to higher 
energy state separated b}' AE. 
In an NMR experiment, one applies strong homogeneous magnetic field causing the 
nuclei to presses. Radiation of energy comparable to AE is then imposed with radio 
frequency transmitter equal to precision or Larmor frequency and the tv^ -'O are said lo be 
in resonance. The energy can be transferred from the source to the sample. The NMR 
signal is obtained when a nucleus is excited from low energy to high energy state. 
1.4 Electron paramagnetic resonance spectroscopy 
EPR spectroscopy [76] is the branch of absorption spectroscopy in which radiation 
having frequency in the microwaxe region is absorbed by molecules possessing electrons 
with unpaired spins. The unpaired electrons in radicals or in complexes of transition 
19 
metal centers with only parlialh filled d orbitals features a spin, the orientation of which 
in a magnetic field can give rise to two energetically different states. For an electron of 
spin S = 1/2, the spin angular momcnlum quantum number will have values of nis = ±1/2. 
hi absence of magnetic field, tlie two \'alues of nis i.e. +1/2 and -1/2 will give rise to a 
doubly degenerate spin energ\ state, if a magnetic field is applied, this degeneracy is 
lifted and leads to the non-degenerate energy levels. The low energy level will have the 
spin magnetic moment aligned with the field and correspond to the quantum number ms = 
-1/2. On the other hand, the high energ\ slate will have the spin magnetic moment 
opposed to the field and correspond to the quantum number m^  = +1/2. The energy E of 
the transition is given by; 
E = hx = gPHo 
Where h is Planck's constant, v the frequenc} of radiation, P the Bohr magneton. Ho the 
field strength and g the spectroscopic splitting factor. 
The magnitude of g is characteristic for the paramagnetic system and depends upon the 
orientation of the molecule with respect to the magnetic field. From the observed value of 
g it is possible to determine o.xidation and spin slates or even details in the coordination 
sphere of the metal centers, li'lhe paramagnetic radical or ion has g value independent of 
the orientation of the crystal it is said to be isotropic and if the value of g depends on the 
orientation of the crystal and is said to be anisotropic. 
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1.5 Conductance measurements 
The conductivit}'' measurement is one of the simplest and easily available techniques used 
to study the nature of the complexes. It gives direct information regarding whether a 
given compound is ionic or covalent. For this purpose, the measurement of molar 
conductance (Am) which is related to the conductance value in the following manner is 
made. 
cell constant x conductance 
Am = 
concentration ol solute expressed in mol cm"' 
Conventionally, solutions of 1x10"' M strength are used for the conductance 
measurements. Molar conductance values of different types of electrolytes in a few 
solvents are given as, 1:1 electrohte has a value of 80-115 ohm" cm^ mol" in MeOH, 
65-90 ohm"' cm' mol"' in DMF, 78-80, 50-70 ohm"' cm' mol"' DMSO and 35-45 ohm"' 
-) I 
cm" mol" in EtOH [77,78]. Suiiilarly a solution of 2:1 electrolyte has a value of 160-220 
ohm" cm mol"' in MeOH. 130-170 ohm"' cm" mol"' in DMF and 70-90 ohm"' cm mol" 
in EtOH. 
2. DNA binding studies 
Calf thymus DNA was procured from Sigma Chemical Company and Tris base was 
obtained from E. Merck. All the experiments involving interaction of the complexes with 
CT DNA were conducted in buffer containing Tris HCl (0.01 M) adjusted to pH 7.2 with 
hydrochloric acid. The CT DNA was dissolved in Tris HCl buffer and was dialyzed 
against the same buffer overnight. Solutions of CT DNA gave ratios of UV absorbance at 
260 and 280 nm above 1.8. indicating that the DNA was sufficiently free of protein [79]. 
DNA concentration per nucleotide was determined by absorption spectroscopy using the 
molar absorption coefficient 6600 dm' mof' cm' at 260 nm [80]. The stock solution was 
stored at 4°C. 
2.1 Cyclic voltammetr}' 
Cyclic voltammeti7 invoh-es the measurement of current-voltage curves under diffusion 
controlled, mass transfer conditions at a stationary electrode, utilizing symmetrical 
triangular scan rates ranging from a few millivolts per second to hundred volts per 
second. The triangle returns at the same speed and permits the display of a complete 
polarogram with cathodic (reduction) and anodic (oxidation) waveforms one above the 
other. Two seconds or less is required to record a complete polarogram [81]. 
Consider the reaction 
0 + ne • R (i) 
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Assuming semi-infinite linear diffusion and a solution containing initially only species 0. 
with the electron held at a potential Ei where no electrode reaction occurs. The potential 
is swept linearly at v v/sec so that the potential at an)' time is 
E(t) = E,--\t 
or Epeak = E°-0.0285 
The rate of electron transfer is so rapid ai the electrode surface that species 0 and R 
immediately adjust to the ratio according to the Nernst equation, which is as follows, 
Co(0,t) = Co* - [nFA(KDo)"']'' | I(7i)(t-xr"- dx (ii) 
I = nFACo*(nDoa)''-x(at) (hi) 
Redox (electron-transfer) reactions of metal complexes can be investigated by cyclic 
voltammetry. An electrode is immersed in a solution of the complex and voltage is swept 
while current flow is monitored. No current flows until oxidation or reduction occurs. 
After the voltage is swept over a set range in one direction, the direction is reversed and 
swept back to the original potential. The cycle may be repeated as often as desired. 
Figure 6 shows the cyclic voltammograms (CV) for a reversible one-electron redox 
reaction such as, 
CpFe(CO)LMe ^ CpFe(CO)LMe" + e" 
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Sweeping the potential in an increasing direction oxidize tlie complex as the anodic 
current la flows; re\'ersible reduction of CpFe(CO)LMe' generates cathodic current 1,; on 
the reverse sweep. The magnitude of the current is proportional to the concentration of 
the species being oxidized or reduced. 
The measured parameters of interest on these cyclic voltammograms are Ipa/lpc the ratio 
of peak currents, Epa - Epe tlie separation of peak potentials and the formal electrode 
potential E°. For a Nernstian wa\'e with stable product, the ratio Ipa/lpc = 1 regardless of 
scan rate, E" and diffusion coefficient, when Ipa is measured from the decaying current as 
a base line. The difference between Epa and Epc (AEp) is a useful diagnostic test of a 
Nernstian reaction. Although AEp is slightly a function of E". it is always close to Z.SRT/ 
nF. 
(b) 
Figure 6. (a) Cyclic potenlicil sweep (b) Resulting cyclic voltammogram 
The technique yields information about reaction reversibilities and also offers a rapid 
means of analysis for suitable s>'Stems. The method is particularly valuable to study 
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interaction of metal ions to DNA as it provides a useful compliment to other methods of 
investigation, such as UV-'Vis spectroscopx. Cyclic voltammetric studies were 
accomplished on a CH Instrument Electrochemical analyzer using a three-electrode 
configuration comprised of a Pt wire as the auxiliary electrode, a platinum micro-cylinder 
as the working electrode and Ag/AgCl as the reference electrode. Electrochemical 
measurements were made under nitrogen atmosphere. All electrochemical data were 
collected at 298 K and are uncorrected for junction potentials. 
2,2 Absorption spectral studies 
In a closed constant volume s} stem, the rate of a chemical reaction is defined as the rate 
of change of the concentration of any of the reactants and products with time. The 
concentration can be expressed in any units of quantity per unit volume e.g. moles per 
litre, moles per cubic centimeter. The rate will be defined as positive quantity regardless 
of the component whose concentration change is measured. 
The rate of a chemical reaction is not measured directly instead the concentration of one 
of the reactants or products is determined as a function of time. A common procedure for 
determining the reaction order is to compare the experimental results with integrated rate 
equations for reactions of different orders. For a first order rate equation, integrating by 
separate \'ariables using integration limits such that at t = 0. c = Co and at t = t, c = c [821. 
2S 
-dc/dt - kc 
or In (Co/c) = kt 
The intrinsic binding constant K[, of tlic complex to CT DNA was determined from 
equation (1). tlirough a plot of [DNA]/ Ca-£f '^s [DNA], where [DNA] represents the 
concentration of DNA. and s.,^  Sf. and Si, the apparent extinction coefficient (Aobs /[M]). 
tlie extinction coefficient for free metal complex (M). and the extinction coefficient for 
the free metal complex (M) in the full> bound form, respectively. In plots of [DNA]/ea-S( 
vs. [DNA], Kb is given by the ratio of slope to intercept [83,84]. These absorption 
spectral studies were performed on USB 2000 Ocean Optics and Shimadzu UV-l'/QO 
PharmaSpec UV/Vis spectrophotometers. 
[DNA] / |8a-e,i = [DNA] / |Sb-St1 + 1/ ^b leirGfl (1) 
Absorption spectral titration experiments were performed by maintaining a constant 
concentration of the complex and varying the nucleic acid/nucleotide concentration. This 
was achieved by diluting an appropriate amount of the metal complex solutions and CT 
DNA stock solutions while maintaining the total volume constant. This results in a series 
of solutions with varying concentrations of C f DNA but a constant concentration of the 
complex. The absorbance (A) was recorded after successive additions of CT DNA. While 
measuring the absorption spectra an equal amount of CT DNA was added to both the 
compound solution and the reference solution to eliminate the absorbance of the CT 
DNA itself 
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2.3 Fluorescence spectral studies 
When molecules that ha\'c absorbed light are in a higher electronic state, they must lose 
their excess energy to return back to the ground state. If the excited molecule returns to 
the ground state by emitting light, it exhibits fluorescence and spectrum thus obtamed is 
called emission spectrum. This phenomenon is generally seen at moderate temperature in 
liquid solution. The emission spectrum is obtained by setting the excitation 
monochromator at the maximum excitation \\a\'elength and scanning with emission 
monochromator. Often an excitation spectrum is first made in order to confirm the 
identity of the substance and to select the optimum excitation wavelength. Further 
experiments were carried out to gain support for the mode of binding of complexes with 
CT DNA. The concentration of free probe (Ct) was obtained from following equation: 
C , -C, (F /Fo-P)( l -P) (2) 
P = F/Fo (3) 
Where Ct is the concentration of the probe added. F and Fo are the fluorescence 
intensities in the presence and absence of DNA. respectively, and P is the ratio of the 
observed fluorescence quantum yield of the bound probe to that of the free probe. The 
value of P was obtained as the intercept b\' extrapolating from a plot of F/Fo (y) vs. 
1/[DNA] (x). 
Cb = C,-C, (4) 
r /C = An-r) (5) 
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Cb is the concentration of binding probe and r is tiie ratio of tlie bound probe per base 
pair. Tlie intrinsic binding constant {K) and the binding site number (n) are calculated by 
using scatchard's equation. Quenching plots are constructed according to the following 
stern-vohner equation: 
lo/I = l+A^. r,,, (6) 
Here IQ and I refer to the lluorescence intensities in the absence and presence of 
ferrocvanide anion. 
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Materials and Methods 
All reagents NA-ere of the commercial grade and were used without further purification. 
Nickel chloride hexahydrate (NiCl2.6H20), copper chloride dihydrate (CuCl2.2H?0), 
Tris-base (E. Merck), Pyridine-2-carboxylic acid (Sigma-Aldrich Chemie), imidazole (E. 
Merck) and SnCU.SHiO (Lancaster) were used as receixed. Calf-thymus DNA (CT-
DNA) was purchased from Sigma Chemical Co. 
Microanalysis (%CHN) was performed on a Perkin Elmer elemental analyzer model 
2400. Molar conductances were measured at room temperature on a Digsun Electronic 
conductivity bridge, hifra red spectra were collected by using KBr pellets on an Interspec 
2020 FT-IR spectrometer. UV-Vis spectra were recorded on a Shimadzu lJV-1700 
pharmaspec UV/Vis spectrophotometer using cuvettes of 1 cm path length and the data 
were reported as Amax/nm. The EPR spectrum ol'the copper complex was acquired on a 
Varian Ell2 spectrometer using X-band frequency (9.1 GHz) at liquid nitrogen 
temperature in solid state. The H. 'C and 'Sn spectra were recorded on a Bruker DR^ K-
400 spectrometer, operating at room temperature. Chemical shifts were reported on the 5 
scale in parts per million (ppm). Emission spectra were recorded on a Hitachi F-2500 
fluorescence spectrophotometer. 
All the experiments involving interaction of complexes with CT DNA were performed in 
double-distilled Tris-HCl buffer containing Tris (0.01 M) and pH was adjusted to pH 7.2 
with HCl. Solutions of calf-thymus DNA in buffer gave a ratio of UV absorbance at 260 
and 280 nm of ca. 1.9:1 indicating that DN.A was free from protein. Cyclic voltammetry 
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was performed on CH-instrumcnt eleclrochemical analyzer. The supporting electrolyte 
was 0.4 M KNO3 in water. All samples were purged with nitrogen prior to measurements 
at room temperature. A three-electrode configuration comprised of a Pt micro cylinder as 
a working electrode. Pt wire as auxiliary electrode and an Ag/AgCl electrode as a 
reference electrode were used. 
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Synthesis 
Synthesis of C,2Hi2N206SnCl2 [IJ 
The complex 1 was prepared according to the reported procedure, which is described as 
follows [42]. 
To a solution of pyridine-2-carbox)'lic acid (10 nimol, 1.23 g) in 20 ml of MeOfI was 
added a methanolic solution of SnCU.SH^O (5 mmol. 1.75 g) in a 2:1 molar ratio. The 
mixture was heated under retlux for 48 h at 65 °C. The white crystalline product was 
obtained after slow evaporation of solvent at room temperature, which was filtered, 
washed with methanol, and dried in vacuo. Yield 70%, m.p. 160°C. Anal. Calc. for 
CizHnN.OeSnCh: C 30.67, H 2.57, N 5.96, found: C 30.84, H 2.63, N 6.04. IR (KBr, 
cm''): Umax 1670 (sym COO); 1344 (as}m COO); 3400 (H2O), 655 (Sn-0): 333 (Sn-N): 
275 (Sn-Cl). Molar conductance: A,,, (1x10"^ MeOH): 24.7 Q"'cm"'mol"' (non-
electrolyte). 'H N M R (400MI-1Z, DMS0-d6, 8) 9.1-7.8 (ArH). ""Sn NMR (149 MHz, 
DMSO-d6,5)-591.0. 
Synthesis of CsHieNeOioNiSnCl 2121 
To a solution of NiCl2.6H20 (5 mmol, 1.18 g) in 10 niL of MeOH was added a 
methanolic solution of imidazole (10 mmol, 0.680 g) in a 1:2 molar ratio and the 
resulting solution was stirred for 3 h at 35.00±5.00 °C. A methanolic solution of complex 
1 (5 mmol, 2.35 g) was added to the abo\'e reaction mixture and refluxed for 48 h. The 
solvent was reduced by rotary e\'aporator to give a green colored solid product, which 
was filtered, washed with methanol and dried in vacuo. Yield 58%, m.p. > 300°C 
(decompose). Anal. Calcd. for CisH.eNeOioNiSnCl 2: C 29.42, H 3.56. N 11.44, found: C 
29.62. H 3.61. N 11.31. IR (KBr, cm"'): i)„,,^ 1670 (sym COO); 1344 (asym COO); 3450 
(H2O); 651 (Sn-0); 333 (Sn-N); 275 (Sn-Clj; 535 (Ni-N). Molar conductance: An, (1x10" 
\ H2O): 29.7 a'cm"'mor' (non-electrolyte). 'H N M R (400MHZ, DMSO-df,, 5) 8.6-7.1 
(ArH). '^ C NMR (76 MHz. DMSO-dfe, 8) 126 ppm (imidazole C). "'^ Sn NMR (149 
MHz, DMS0-d6, 5) -590.9. 
Synthesis of C,8H26N60ioCuSnCl2 [3] 
This complex 3 was prepared b> adopting the similar procedure as described for complex 
2 using CUCI2.2H2O (5 mmol, 0.852 g). The blue colored product was obtained, which 
was filtered and dried in vacuo. Yield 60%, m.p. >300°C (decompose). Anal. Calcd. for 
Ci8H26N60ioCuSnCl2: C 29.23, H 3.54, N 11.36, found: C 29.45, H 3.62, N 11.44. IR 
(KBr, cm"'): u„iax 1650 (sym COO); 1344 (asym COO); 3400 (H2O); 650 (Sn-O); 330 
(Sn-N); 270 (Sn-Cl); 533 (Cu-N). Molar conductance: A^ (IxlO""*, DMSO): 36.0 Q' cm" 
'mof' (non-electrol>te). ' ''^ Sn NMR (149 MHz. DMSO-df,. 6) -622.0. 
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Results and Discussion 
Results and Discussion 
Synthesis of complex 1 was achieved by mixing stoichoimetric amounts of pyridine 2-
carboxylic acid and SnCla 5H2O in 2:1 ratio. The complexes 2 and 3 were prepared in 
situ by mixing a methanolic solution of complex 1 to a solution containing imidazole and 
Ni(Il)/ Cu(ll) ions in a 2:1 molar ratio, respecti\ cly (Scheme 4). 
All the reactions were monitored by TLC (CHCb,/CHiOH. 95:5) and complexes 
synthesized were TLC pure. The yields of the complexes were > 50%. The complexes 
were stable towards air and moisture and soluble in MeOH and DMSO. The empirical 
formulae and the structures of the complexes 1-3 were ascertained by elemental analysis, 
1 I T 
IR. H, and C NMR spectral studies. In complexes 1-3, the coordination geometry 
around metal ions (Sn(IV), Ni(II), Cu(Il)) was octahedral, which was proposed on the 
basis of spectroscopic studies. The molar conductance measurements in methanol show 
that complexes are non-ionic in nature. Energy minimized structures using CS Chem 
Draw 3D Pro 5.0 as shown in Figure 4 validated the proposed structures. DNA binding 
studies were performed with complexes 1 and 3 indicating that complex 3 binds to DNA 
with a greater affinity than complex 1. 
O ,0H 
c 
N 
SnCU.SHjO 
MeOH 
Ox\ . 0 . 
C 
N' 
CI 
I 
Cl 
1 
^Ox/.O 
c 
'N 
.2H,0 
\-°^ 
N' 
Cl 
'Sn^ 
Cl 
. 0 . A) 
C"^ 
'N .2HoO 
MeOH 
H H 
N. 
HoO 
Reflux 
t - 0 P-C 
N- \ / / - N 
;Sh 
U \ O 
N ^ I ^ N - ^ 
M 
HoO OH, 
Cl 
M:' 
Cl 
\^ // 
OH, 
.4H.0 
M= Ni (II) .Cu (II) 
2 , 3 
Scheme 4 
34 
Figure 7. Energy minimized cylindrical bonded three dimensional model of complex 2/3. 
Color scheme: Sn(IV) dark green; Cu(II)/Ni(II) darkblue; O red; C gray; N ocean blue. 
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1 R spectra 
The IR spectra of the complexes 1-3 were recorded in solid state as KBr discs. In the IR 
spectrum of the free pyridine-2-carboxylic acid, bands observed around 1608 cm'' and 
1453 cm' attributed to the asymmetric and symmetric carboxylate stretching vibrations, 
respectively were shifted in the metal complexes, suggesting the coordination of 
carboxylate group to the tin metal ion via deprotonation [85]. Deacon et al. [51] have 
shown that the magnitude of An [AD = i)as(COO') -1)^(000")] can be correlated with the 
coordination modes of the carboxylate anion. The IR spectra of complexes 1-3, reveal 
bands in the regions 1670-1680 cm' and 1340-1344 cm' , corresponding to Das COO ' 
and Ds COO ~ modes, respectivel}' of the coordinated carbox}'lic group. The frequenc} 
difference AD of 326-340 cm'' between asymmetric and symmetric stretching vibration 
suggests monodentate coordination of -COO' group. The coordination of pyridine-2-
carboxylic acid and complex 1 formation was also supported by the presence of medium 
intensity (Sn-N) and (Sn-Cl) bands around -461 and -330 cm'', respectively, in the far-
IR region [86]. 
The IR spectra of the complexes 2 and 3 revealed some notable leatures. Two medium 
intensity bands at -1560 cm'' and -1340 cm'' were assigned to D(C=N) and D(C-N) of the 
imidazole ring, respectively [87]. Additionally, the IR spectra of the complexes 2 and 3 
show the absence of imidazole N-H stretching band at 1240 cm'' providing strong 
evidence for its deprotonation and subsequent coordination to tin metal ion by the 
elimination of HCl molecules. The appearance of a band at -455 cm"' region in the 
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complexes 2 and 3 implied the formation of metal chloride bonds [88]. The conclusive 
evidence for the coordination mode of metal complexes was deduced by the observation 
of new v(M-N) bands around 530-536 cm'' in the far IR region. Absorption bands due to 
the coordinated water molecules were displaced around 3300 cm" . 
NMR Spectra 
The complexes 1-3 were characterized by the 'H . '"'C and ""^ Sn NMR spectroscop). The 
'H NMR and "^Sn NMR spectr a recorded in DMS0-d6 solution showed signals in 
accordance with the proposed structures (Figure 8a, 8b and 9a, 9b). The absence of signal 
at 10.0 - 12.0 ppm in the 'ff NMR spectra of complexes 1 and 2 due to the free 
carboxylic group indicates its deprotonation and coordination to the tin metal ion. Signals 
due to pyridine-2-carboxylic acid moieties were observed as multiplets at 9.13, 8.40, 8.12 
and 7.69 ppm for complex 1 [42]. The characteristic -Nff proton signal of the imidazole 
ring observed in the range 12.00-14.00 ppm was absent in the spectrum of complex 2 
corresponding to the deprotonation of the -NH group [89]. This feature is commensurate 
with the fact that the imidazole group was coordinated to the Sn metal ion. The complex 
2 revealed ''^ C resonance at 126 ppm, which were assigned to carbon skeletons of 
imidazole ligands [90]. 
Sn NMR spectroscopy has been found to be a useful technique for structure 
elucidation. "''Sn NMR of complexes 1-3 displayed signals at around ~ -591 ppm is in 
consistent with the hexacoordinated geometry of tin metal ion [91]. 
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Electronic absorption spectra 
UV-vis spectra of complexes 2 and 3 were recorded in DMSO at room temperature in the 
range of 180-1100 nm. The complexes 2 and 3 exhibited bands at 224 nm and 264 nm 
assigned to intraligand transitions. In \'isible region complex 2 showed absorption bands 
at 664 nm and 899 nm, respectively attributed to d - d transitions of Ni(Il). However, 
complex 3 exhibited a low intensity d - d band at 760 nm assigned to ^Big -^ E^2g 
transition suggesting an octahedral geometry around Cu(ll) metal ion [92]. 
EPR spectrum 
Solid state X-band EPR spectrum of the complex 3 was recorded at a frequency of 9.1 
GHz under the magnetic field strength of 3000±1000 gauss with tetracyanoethylene 
(TCNE) as field marker (g = 2.0027) at LNT. The complex 3 showed an anisotropic 
spectrum with different g|| and gi values. The EPR spectrum of complex 3 consist of 
symmetrical axial line with well defined gp = 2.25 and gi = 2.097 values, and gav = 2.15 
1 ") -} 
computed from the expression gav" = (g|| " "^  2gi'')/3, suggesting an octahedral geometry 
[93]. The trend g|| > gi>ge (2.0023) revealed that the unpaired electron was located in the 
dx"-dv" orbital of the Cu ions characteristic of axial symmetry (Figure 10). 
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Figure 10. EPR spectrum oj copper complex 3 ai LNT 
DNA binding studies 
The binding of the complexes to calf thymus DNA has been studied by a number of 
techniques like absorption titration, fluorescence spectroscopy and cyclic voltammetry. 
Absorption spectral studies: 
The absorption traces of the complexes 1 and 3 with increasing concentration of CT DNA 
(0.06x10"^ to 0.33x10"^ M) are shown in figure 8. The absorption bands at 264 nm, of 
complexes 1 and 3 exhibited a blue shift of 5 nm along with significant hyperchromicity. 
which indicates that the complexes interact with DNA. The hyperchromic effect arises 
due to the damage of double helix structure of CT DNA [94]. The extent of 
hyperchromicity were different 47% and 45% for complexes 1 and 3, respectively, which 
could be due to the presence of central metal ion, Cu(II) in complex 3 The complex 3 
showed significantly high binding affinity than 1. Since complex 1 has one Sn(IV) metal 
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ion - a strong lewis acid, it should display different binding mode (electrostatic) showing 
preferential selectivity to phosphate backbone of DNA helix [95]. While complex 3 
contain heterometallic core (one transition and a non-transition metal ions) of which 
Cu(II) prefers to bind via covalent linkage to N7 of guanine of the DNA double helix 
[96] and Sn(IV) prefers to bind to negati\el> charged phosphate backbone of the DNA 
double helix. Therefore, it is expected that 3 will have more propensity for DNA in 
comparis'on to complex 1. To compare quantitatively binding strength of the complexes 
1 and 3, their intrinsic binding constants (A'b) have been determined by using eqn. (1). 
The intrinsic binding constant (A'b) values were 3.5x10' M" and 1.3x10 M" for 1 and 3, 
respectively. Our experimental A'b \alues are lower than those observed for classical 
intercalators (ethidium-DNA) ruling out the possibility of intercalation of the complexes 
with DNA helix. 
Figure 11. Absorption spectral traces of (a) complex 1 and (b) complex 3 in Tris HCl 
buffer upon addition ofCTDNA. Arrows shoM' the absorbance change upon increasing 
concentration of the CT DNA. 
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Figure 12. Plots of [DNA], Sa-q v.v [DNA] for (he Htralion of (a) complex 1 and (h) 
complex 3 with CT DNA: (u) experimental data points: full lines, linear fitting of the 
data. 
Fluorescence-spectroscopic studies: 
The binding of tlie complexes 1 and 3 to DNA lias been studied by emission titrations. 
Complexes 1 and 3 emit luminescence in tris HCl buffer upon excitation at 264 nm in 
absence of CT DNA. Fixed amount of complexes 1 and 3 were titrated with increasing 
amount of CT DNA (0 - 0.12x10"'* M). as illustrated in figure 10. Titrations led to a 
decrease in the emission intensity of complexes 1 and 3, furnishing indirect evidence for 
the CT DNA binding mode. The relati\'e lluorescence intensity as a function of CT DNA 
concentration (in terms of 1/[DNA]) was plotted. The complex 3 produced a large 
reduction in emission intensity in the presence ofCT DNA in comparison to 1. To furtlier 
demonstrate the binding affmity of complexes 1 and 3 with CT DNA, the quenching 
experiments with [Fe(CN)6] " W'cre carried out (Figure 14,15). Multianionic [FefCN);,] 
as an emission quencher has been found to be able to distinguish the binding mode of the 
complex with DNA [97][98]. The binding of the probe to the helix should protect the 
fluorophore from quenching by the anionic |Fe(CN)(3]'*". due to the electrostatic field 
surrounding the helix. High binding constants should correspond to better protection by 
the DNA and a stronger inhibition of quenching by anionic species. The magnitude of/Cs\ 
should be higher for the free probe than that bound with DNA. The plot of free 
complexes 1 and 3 gave K^^ 8.3 x 10'* M"' and 10 \ 10"* M"' respectively (Figure 17). fhe 
K^^ value of complex 3 is greater in the presence of CT DNA as compared to complex 1 
indicates that 3 was bound more strongly to the C f DNA. This could be explained by the 
fact that complexes free in solution or bound on the helix exterior are accessible to the 
quencher while those bound in the helix interior are much less accessible [99]. 
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Figure 13. Emission spectra of (a) complex 1 and (h) complex 3 in presence of CT DNA 
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Figure 16. Relative fluorescence intensity as a function of CT DNA of (a) complex 1 and 
(b) complex 3. 
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Cyclic Voltammetry 
Cyclic voltammogram of complex 3 exhibited quasi-reversible one electron redox 
process involving the Cu /Cu couple with an anodic peak potential Ep,, of-0.335V and 
cathodic peak potential Epc of 0.969V at scan rate 0.3 Vs"', and ratio of anodic and 
cathodic peak currents Ipa / Ipc is 1.568. For this couple, the difference between cathodic 
and anodic peak potential, AEp, and formal peak potential E1/2 are 0.634 V and 0.652 V 
respectively. Keeping all the parameters constant, quasi-reversibility of the electron 
transfer was maintained in the presence of CT DNA. On interaction of the complex 3 
with CT DNA, the shift in the AEp value 0.627 V as well as in the E1/2 value (0.632 V) 
were observed, indicating that complex 3 binds with CT-DNA [100]. At different scan 
rate, the voltammogram does not show any major changes. 
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Conclusion 
The complexes 1-3 were syiilhesized and characterized b}' employing spectroscopic (IP.. 
'H , '^C, and ""^ Sn NMR. EPR. UV-visible) and analytical techniques, hi complexes 1-3, 
the geometry of metal ions Sn(]V). Ni(Il) and Cu(ll) was octahedral. The complexes 
were titrated with CT DNA to study their binding affinity for molecular target DNA and 
the Xb values for 1 and 3 are 3.5x10' M"' and 1.5x10'^  M''. respectively. The magnitude 
of binding of heterobimetallic complex 3 has increased many fold in comparison to 
monometallic complex 1 clearl}' indicating greater propensit}' of 3 for CT DNA. The 
mode of binding is purely electrostatic in addition to coordinate covalent preference of 
copper in 3, which has been ascertained by the "hyperchromic effect" and blue shift in 
absorbances of both 1 and 3 on addition of CT DNA, The emission quenching of these 
complexes by [Fe(CN)6]'*" depressed when bound to DNA. The comparative CT DNA 
binding studies of complex 1 and 3 revealed increase in the binding strength which is due 
to the presence of two metal ions having preferential selecti\ity (Cu(II) prefers to bind 
covalently to the guanine base at the N7 position while Sn(lV) interacts electrostatically 
through the phosphate backbone of DNA double helix) and corroborates well with our 
results of UV-vis and other studies. Thus, we have designed and s\'nthesized a novel 
potential therapeutic agent, which warrants \'igorous in vitro and in vivo investigations. 
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